Selected 2004 Venture Capital Transactions as Company Counsel

Selected 2004 Venture Capital Transactions as Company Counsel

Publication

In 2004, we served as company counsel in more than 150 venture financings raising more than $1.5 billion, including some of the largest and most prominent deals of the year. In the past five years, we have served as company counsel in more than 750 venture financings raising more than $10 billion. We are counsel to more venture capital-backed companies in the eastern half of the United States than any other law firm in the country. Selected venture financings from 2004 are listed below:

  • A123 Systems — $20.0 million
  • Acopia Networks— $25.0 million
  • Aegis Semiconductor— $10.0 million
  • Airwide Solutions— $10.0 million
  • Archivas— $10.0 million
  • Authoria— $10.5 million
  • Compound Therapeutics — $15.5 million
  • Context Media— $11.0 million
  • CoreStreet — $8.5 million
  • Endeca Technologies— $15.0 million
  • Evident Software— $10.0 million
  • Gloucester Pharmaceuticals— $29.0 million
  • Icera— $22.5 million
  • Idenix Pharmaceuticals— $75.6 million
  • IMlogic — $16.0 million
  • Infinity Pharmaceuticals — $25 million
  • Invento Networks— $10.0 million
  • Kalido Holdings— $10.0 million
  • Microbia— $40.0 million
  • Mobile Cohesion— $6.0 million
  • Momenta Pharmaceuticals— $20.5 million
  • Neotropix— $10.0 million
  • Netezza — $15 million
  • NxStage — $20 million
  • Ounce Labs— $10.0 million
  • PharMetrics — $8.0 million
  • Polychromix — $8.0 million
  • Propagate Networks— $8.0 million
  • SiCortex— $21.0 million
  • Softricity — $7.5 million
  • Starent Networks— $25.0 million
  • SurfKitchen— $17.5 million
  • Transitive — $11.5 million
  • Veveo.tv — $14 million
  • Virtual Iron — $12 million
  • VistaPrint Limited— $52.0 million

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.